Senate LDA lobbying filing
CARDINAL HEALTH INC
Reported income
not reported
Reported expenses
$740.0K
Tracked program mentions1
Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.
- Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chain”matched 2+ title words
Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues…
Lobbying activities4
Health IssuesHCR
Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025; H.R. 4313 Hospital Inpatient Services Modernization Act).
ManufacturingMAN
Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.
Tariff (miscellaneous tariff bills)TAR
Issues related to tariffs, trade, and U.S. trade policy.
Trade (domestic/foreign)TRD
Issues related to tariffs, trade, and U.S. trade policy.
Lobbyists4
- ABIGAIL BARNES
- ANGELEINE COMTE
- JERRICA MATHIS
- REBECCA MCGRATH
Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.